By Michael Erman and Julie Steenhuysen
(Reuters) -U.S. Health Secretary Robert F. Kennedy Jr. plans to announce that use of Kenvue's popular over-the-counter pain medication Tylenol in pregnant women is potentially linked to autism, contrary to medical guidelines that say it is safe to use, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Kennedy, in the report, will also suggest a medicine derived from folate called folinic acid can be used to treat symptoms of autism in some people, the WSJ reported.
The U.S. Department of Health and Human Services said that until the final report is released, claims about its contents are speculation. "We are using gold-standard science to get to the bottom of America's unprecedented rise in autism rates," the spokesperson said.
Shares of Kenvue fell 14% after the report. Tylenol, whose active ingredient is acetaminophen, is a widely used pain reliever, including by pregnant women.
https://www.yahoo.com/news/articles/kennedy-hhs-tylenol-pregnancy-autism-175002163.html